BioCentury
ARTICLE | Clinical News

Ruconest conestat alfa regulatory update

April 1, 2013 7:00 AM UTC

Pharming said EMA granted approval to allow contract manufacturing organization Sanofi Chimie to manufacture Ruconest conestat alfa to treat acute attacks of hereditary angioedema (HAE) at its Aramon...